Caillet C - Search Results

1

Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase.

Tsai C, Caillet C, Hu H, Zhou F, Ding H, Zhang G, Zhou B, Wang S, Lu S, Buchy P, Deubel V, Vogel FR, Zhou P. Tsai C, et al. Among authors: caillet c. Vaccine. 2009 Nov 12;27(48):6777-90. doi: 10.1016/j.vaccine.2009.08.056. Epub 2009 Sep 2. Vaccine. 2009. PMID: 19732860 Free PMC article.

2

Emulsion-based adjuvants for influenza vaccines.

Vogel FR, Caillet C, Kusters IC, Haensler J. Vogel FR, et al. Among authors: caillet c. Expert Rev Vaccines. 2009 Apr;8(4):483-92. doi: 10.1586/erv.09.5. Expert Rev Vaccines. 2009. PMID: 19348563 Free article. Review.

3

AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.

Caillet C, Piras F, Bernard MC, de Montfort A, Boudet F, Vogel FR, Hoffenbach A, Moste C, Kusters I. Caillet C, et al. Vaccine. 2010 Apr 19;28(18):3076-9. doi: 10.1016/j.vaccine.2010.02.050. Epub 2010 Mar 1. Vaccine. 2010. PMID: 20193791

4

Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study.

Waldock J, Remarque EJ, Zheng L, Ho S, Hoschler K, Neumann B, Sediri-Schön H, Trombetta CM, Montomoli E, Marchi S, Lapini G, Zhou F, Lartey SL, Cox RJ, Facchini M, Castrucci MR, Friel D, Ollinger T, Caillet C, Music N, Palladino G, Engelhardt OG; FLUCOP consortium. Waldock J, et al. Among authors: caillet c. Front Immunol. 2023 Apr 18;14:1155552. doi: 10.3389/fimmu.2023.1155552. eCollection 2023. Front Immunol. 2023. PMID: 37143658 Free PMC article.

5

Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study.

Waldock J, Zheng L, Remarque EJ, Civet A, Hu B, Jalloh SL, Cox RJ, Ho S, Hoschler K, Ollinger T, Trombetta CM, Engelhardt OG, Caillet C. Waldock J, et al. Among authors: caillet c. mSphere. 2021 Aug 25;6(4):e0056721. doi: 10.1128/mSphere.00567-21. Epub 2021 Jul 28. mSphere. 2021. PMID: 34319129 Free PMC article.

6

Vaccination of macaques with adjuvanted formalin-inactivated influenza A virus (H5N1) vaccines: protection against H5N1 challenge without disease enhancement.

Ruat C, Caillet C, Bidaut A, Simon J, Osterhaus AD. Ruat C, et al. Among authors: caillet c. J Virol. 2008 Mar;82(5):2565-9. doi: 10.1128/JVI.01928-07. Epub 2007 Dec 19. J Virol. 2008. PMID: 18094159 Free PMC article.

7

Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.

Bernard MC, Barban V, Pradezynski F, de Montfort A, Ryall R, Caillet C, Londono-Hayes P. Bernard MC, et al. Among authors: caillet c. PLoS One. 2015 Apr 2;10(4):e0121518. doi: 10.1371/journal.pone.0121518. eCollection 2015. PLoS One. 2015. PMID: 25837802 Free PMC article.

8

Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore.

Harenberg A, Begue S, Mamessier A, Gimenez-Fourage S, Ching Seah C, Wei Liang A, Li Ng J, Yun Toh X, Archuleta S, Wilder-Smith A, Shek LP, Wartel-Tram A, Bouckenooghe A, Lang J, Crevat D, Caillet C, Guy B. Harenberg A, et al. Among authors: caillet c. Hum Vaccin Immunother. 2013 Nov;9(11):2317-25. doi: 10.4161/hv.25562. Epub 2013 Jul 9. Hum Vaccin Immunother. 2013. PMID: 23839107 Free PMC article. Clinical Trial.

9

Optimized enzyme-linked immunosorbent assay for detecting cytomegalovirus infections during clinical trials of recombinant vaccines.

Pagnon A, Piras F, Gimenez-Fourage S, Dubayle J, Arnaud-Barbe N, Hessler C, Caillet C. Pagnon A, et al. Among authors: caillet c. J Clin Virol. 2017 Nov;96:99-104. doi: 10.1016/j.jcv.2017.10.004. Epub 2017 Oct 9. J Clin Virol. 2017. PMID: 29035763

10

An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study.

Waldock J, Weiss CD, Wang W, Levine MZ, Jefferson SN, Ho S, Hoschler K, Londt BZ, Masat E, Carolan L, Sánchez-Ovando S, Fox A, Watanabe S, Akimoto M, Sato A, Kishida N, Buys A, Maake L, Fourie C, Caillet C, Raynaud S, Webby RJ, DeBeauchamp J, Cox RJ, Lartey SL, Trombetta CM, Marchi S, Montomoli E, Sanz-Muñoz I, Eiros JM, Sánchez-Martínez J, Duijsings D, Engelhardt OG. Waldock J, et al. Among authors: caillet c. Front Immunol. 2023 Feb 28;14:1129765. doi: 10.3389/fimmu.2023.1129765. eCollection 2023. Front Immunol. 2023. PMID: 36926342 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters